SRZN Surrozen, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$24.17
Price · Aug 19, 2026
Fundamentals as of May 6, 2026

SRZN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$24.17
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$10 – $35

SRZN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
SRZN
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
SRZN
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
SRZN
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
SRZN
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
SRZN
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
SRZN
Peer Median

SRZN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 11 analysts
  • Strong Buy 3 27.3%
  • Buy 7 63.6%
  • Hold 1 9.1%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

4 analysts · 2026-08-15
Median target $43.00 +77.9%
Mean target $43.00 +77.9%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-5.6%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.41 $-1.31 0.90%
March 31, 2026 $-11.65 $-1.11 -10.5%
Dec. 31, 2025 $-14.03 $-1.21 -12.8%
Sept. 30, 2025 $-8.36 $-1.16 -7.2%
June 30, 2025 $2.55 $-1.13 3.7%
March 31, 2025 $-7.43 $-1.82 -5.6%
Dec. 31, 2024 $-9.10 $-1.37 -7.7%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
SRZN
MYGN $575M -1.6 -1.6% -44.4% -96.8% 69.9%
ANIK $133M -12.6 -5.9% -9.6% -7.5% 56.6%
TRDA $394M -3.0 -87.9% -565.5% -41.9%
RNAC $188M -1.4 -92.8% -4658.6% 202.4%
SION $1.84B -21.9 -23.4%
ZSQR
MGNX $102M -1.4 -0.31% -49.9% -87.0%
ALXO $61M -0.6 -225.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 70 filers · $294.3M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
29 (+17 vs prior Q) 15 (+4 vs prior Q) 16 (+1 vs prior Q) 11 (-2 vs prior Q) +1.4M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Column Group LLC $49,744,853 1,916,950 16.90% Shares
TCG Crossover Management, LLC $38,226,971 1,473,101 12.99% Shares
Boxer Capital Management, LLC $26,963,591 1,105,683 9.16% Shares
MILLENNIUM MANAGEMENT LLC $17,725,900 683,079 6.02% Shares
Point72 Asset Management, L.P. $17,237,858 664,272 5.86% Shares
Venrock Adviser, LLC $16,424,559 632,931 5.58% Shares
PERCEPTIVE ADVISORS LLC $13,078,411 503,985 4.44% Shares
Spruce Street Capital LP $11,211,438 432,040 3.81% Shares
VANGUARD CAPITAL MANAGEMENT LLC $10,186,673 392,550 3.46% Shares
BRAIDWELL LP $10,140,040 390,753 3.45% Shares
Kalehua Capital Management LLC $9,995,369 385,178 3.40% Shares
Vestal Point Capital, LP $7,906,161 304,669 2.69% Shares
STEMPOINT CAPITAL LP $7,087,983 273,140 2.41% Shares
5AM Venture Management, LLC $7,038,938 271,250 2.39% Shares
Vivo Capital, LLC $6,747,000 260,000 2.29% Shares
Balyasny Asset Management L.P. $5,320,579 205,032 1.81% Shares
ACUTA CAPITAL PARTNERS, LLC $4,499,600 173,395 1.53% Shares
GEODE CAPITAL MANAGEMENT, LLC $4,367,718 168,284 1.48% Shares
REGENTS OF THE UNIVERSITY OF CALIFORNIA $3,456,722 133,207 1.17% Shares
STATE STREET CORP $3,453,530 133,084 1.17% Shares
GOLDMAN SACHS GROUP INC $2,634,574 101,525 0.90% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $2,300,545 88,653 0.78% Shares
Euclidean Capital LLC $2,275,711 87,696 0.77% Shares
TWO SIGMA INVESTMENTS, LP $1,845,538 71,119 0.63% Shares
VANGUARD FIDUCIARY TRUST CO $1,545,971 59,575 0.53% Shares
ArrowMark Colorado Holdings LLC $1,430,442 55,123 0.49% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $1,324,125 51,026 0.45% Shares
Eversept Partners, LP $1,239,813 47,777 0.42% Shares
Walleye Capital LLC $1,007,690 38,832 0.34% Shares
Ellsworth Advisors, LLC $855,977 39,283 0.29% Shares
BANK OF AMERICA CORP /DE/ $812,105 31,295 0.28% Shares
VANGUARD GROUP INC $799,814 35,390 0.27% Shares
UBS Group AG $758,493 29,229 0.26% Shares
FRED ALGER MANAGEMENT, LLC $622,904 24,004 0.21% Shares
XTX Topco Ltd $436,687 16,828 0.15% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $422,907 16,297 0.14% Shares
LMR Partners LLP $351,804 13,557 0.12% Shares
RENAISSANCE TECHNOLOGIES LLC $321,105 12,374 0.11% Shares
Alyeska Investment Group, L.P. $264,379 10,188 0.09% Shares
Fisher Asset Management, LLC $255,348 9,840 0.09% Shares
Nuveen, LLC $253,791 9,780 0.09% Shares
RHUMBLINE ADVISERS $210,965 8,130 0.07% Shares
BNP PARIBAS FINANCIAL MARKETS $208,353 8,029 0.07% Shares
WELLS FARGO & COMPANY/MN $173,813 6,698 0.06% Shares
MetLife Investment Management, LLC $121,939 4,699 0.04% Shares
Bank of New York Mellon Corp $110,002 4,239 0.04% Shares
NEW YORK STATE COMMON RETIREMENT FUND $106,395 4,100 0.04% Shares
China Universal Asset Management Co., Ltd. $94,718 3,650 0.03% Shares
MORGAN STANLEY $94,458 3,640 0.03% Shares
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $87,737 3,381 0.03% Shares
CITIGROUP INC $78,654 3,031 0.03% Shares
JPMORGAN CHASE & CO $78,292 3,044 0.03% Shares
Vanguard Global Advisers, LLC $66,692 2,570 0.02% Shares
Police & Firemen's Retirement System of New Jersey $56,208 2,166 0.02% Shares
BlackRock, Inc. $53,976 2,080 0.02% Shares
STRS OHIO $36,330 1,400 0.01% Shares
NORTHERN TRUST CORP $29,817 1,149 0.01% Shares
BARCLAYS PLC $28,805 1,110 0.01% Shares
Legal & General Group Plc $18,554 715 0.01% Shares
Ameritas Investment Partners, Inc. $17,283 666 0.01% Shares
Russell Investments Group, Ltd. $15,232 587 0.01% Shares
Tower Research Capital LLC (TRC) $11,107 428 0.00% Shares
FMR LLC $9,031 348 0.00% Shares
ROYAL BANK OF CANADA $6,000 244 0.00% Shares
State of Wyoming $5,501 212 0.00% Shares
DEUTSCHE BANK AG\ $3,711 143 0.00% Shares
Sterling Capital Management LLC $675 26 0.00% Shares
PRICE T ROWE ASSOCIATES INC /MD/ $564 21,715 0.00% Shares
ACADIAN ASSET MANAGEMENT LLC $39 1,508 0.00% Shares
Caitong International Asset Management Co., Ltd $26 1 0.00% Shares

Company insiders 19 insiders · 5 officers · 9 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Craig C Parker Chief Executive Officer May 1, 2026 M 16,553 0 1 $-150,785
Andrew Pedrum Maleki Chief Financial Officer Nov. 12, 2025 A 0 0 $0
Charles O Williams Chief Operating Officer May 1, 2026 M 16,571 0 2 $-98,976
Yang Li Exec. Vice President, Research May 1, 2026 M 17,216 0 2 $-75,010
Geertrui Vanhove Chief Medical Officer Aug. 12, 2021 A 0 0 $0
Mace Rothenberg Director May 13, 2026 A 0 0 $0
Mary Haak-Frendscho Director May 13, 2026 A 0 0 $0
Anna Berkenblit Director May 13, 2026 A 0 0 $0
David J Woodhouse Director May 13, 2026 A 0 0 $0
Tim Kutzkey Director May 13, 2026 A 1,016,658 18 0 $5,984,632
Christopher Y Chai Director May 13, 2026 A 0 0 $0
Eric Bjerkholt Director May 13, 2026 A 0 0 $0
Mitchell J Blutt MD Director Nov. 23, 2020 A 410,000 0 0 $0
Benny Soffer Aug. 11, 2021 A 1,885,000 0 0 $0
Kevin Harold Livingston Aug. 11, 2021 A 1,885,000 0 0 $0
Consonance Life Sciences Aug. 11, 2021 A 1,885,000 0 0 $0
Jennifer Jarrett Aug. 11, 2021 D 30,000 0 0 $0
Christopher Haqq Aug. 11, 2021 D 30,000 0 0 $0
Donald J Santel Aug. 11, 2021 D 30,000 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
The Column Group III GP, LP, The Column Group III, LP, The Column Group III-A, LP, The Column Group Opportunity III, LP, The Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, Peter Svennilson ×3 filings May 18, 2026 29.30% Amendment SEC
Consonance Capital Management LP, Consonance Capman GP LLC, Consonance Life Sciences, LLC, Mitchell Blutt, Benny Soffer, Kevin Livingston ×2 filings Sept. 29, 2021 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 8 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.04% 24,670 SH Aug. 8, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 42,455 SH Aug. 8, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.01% 7,916 SH Aug. 8, 2026 Daily
IWO · iShares Trust 0.01% 67,290 SH Aug. 8, 2026 Daily
IWM · iShares Trust 0.00% 174,956 SH Aug. 8, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 102,939 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 282,365 SH Aug. 8, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 655 SH Aug. 8, 2026 Daily